Adverse Childhood Experiences
0
Pipeline Programs
2
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Angeles TherapeuticsCA - Los Angeles
2 programsBehavioral: Telephone-based ACEs care coordinationN/A1 trial
Garnering Resilience in Traumatized youth and familiesN/A1 trial
Active Trials
Colorado TherapeuticsCO - Louisville
1 programImplementation Strategy of ACEs ScreeningsN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
2027
2028
Angeles TherapeuticsGarnering Resilience in Traumatized youth and families
Angeles TherapeuticsBehavioral: Telephone-based ACEs care coordination
Colorado TherapeuticsImplementation Strategy of ACEs Screenings
Clinical Trials (3)
Total enrollment: 7,957 patients across 3 trials
The THRIVE Study: Teaching Healthy Regulation in Individuals & Vulnerable Environments
Start: Apr 2025Est. completion: Aug 2028210 patients
N/ARecruiting
Testing a Scalable Model For ACEs-Related Care Navigation
Start: Oct 2022Est. completion: Nov 2023102 patients
N/ACompleted
Implementation of Adverse Childhood Experiences (ACEs) Policy
Start: Feb 2022Est. completion: Apr 20247,645 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 7,957 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.